Treatment With Tucatinib in Patients With an Isolated Brain Progression of a Metastatic Breast Cancer

NCT05041842 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

53

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Breast Cancer With a Isolated Brain Progression

Interventions

DRUG: Tucatinib
DRUG: Pertuzumab
DRUG: Trastuzumab
DRUG: Hormone therapy
DRUG: Pertuzumab/ Trastuzumab

Sponsor

UNICANCER

Collaborators

[object Object]
[object Object]